Decreasing Trend in Mortality of Chronic Myelogenous Leukemia Patients After Introduction of Imatinib in Japan and the U.S.

PURPOSE. Although the impact of imatinib in improving survival outcomes in chronic myelogenous leukemia (CML) patients has been widely reported, its impact on mortality from CML has not been evaluated. A survival benefit demonstrated in clinical trials does not simply translate to a decrease in mort...

Fuld beskrivelse

Na minha lista:

Bibliografiske detaljer
Main Authors:	Chihara, Dai, Ito, Hidemi, Matsuda, Tomohiro, Katanoda, Kota, Shibata, Akiko, Saika, Kumiko, Sobue, Tomotaka, Matsuo, Keitaro
Format:	Artigo
Sprog:	Inglês
Udgivet:	AlphaMed Press 2012
Fag:	Leukemias
Online adgang:	https://ncbi.nlm.nih.gov/pmc/articles/PMC3528387/ https://ncbi.nlm.nih.gov/pubmed/22971523 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1634/theoncologist.2012-0197
Tags:	Tilføj Tag Ingen Tags, Vær først til at tagge denne postø!

Decreasing Trend in Mortality of Chronic Myelogenous Leukemia Patients After Introduction of Imatinib in Japan and the U.S.

Lignende værker